Flagship explainer
What drives Nuvation Bio Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$205M | FY2025 |
| |
| Income before tax | −$205M | FY2025 |
|
| Operating income | −$213M | FY2025 |
|
| $62.9M | FY2025 |
| |
| Ending assets | $595M | FY2025 |
|
| Beginning assets | $541M | FY2024 |
|
| $306M | FY2025 |
| |
| $464M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0000950170-25-034903
- SEC filingFiling detailsAccession 0001193125-26-085584